ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982